2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$139.64+$0.11 (+0.08%)
Price as of Oct 22, 2026 7:30 PM EDT- $8.9BMarket Cap
- 87.86%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$139.64+$0.11 (+0.08%)
PTGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $139.53 | ||
Change | +$0.09 (+0.07%) | ||
Open | $137.49 | ||
High | $141.38 | ||
Low | $136.07 | ||
Previous Close | $138.08 | ||
Volume | 404,387 | ||
30-Day Average Volume | 827,199 | ||
1-Week Change | 1.32% | ||
1-Month Change | -4.76% | ||
1-Year Change | 87.86% | ||
3-Year Change | 857.56% | ||
5-Year Change | 344.70% | ||
Fundamentals | |||
Shares Outstanding | 64.7M | ||
Total Assets | $885.5M | ||
Market Cap | $8.9B | ||
Enterprise Value | $8.5B | ||
Period: QTR TTM FY | |||
Revenue | $213.5M | ||
Net Income | $162.8M | ||
Free Cash Flow | $218.9M | ||
EBIT | $165.1M | ||
EBITDA | $165.5M | ||
Net Working Capital | $770.0M | ||
EPS | $2.29 | ||
Enterprise Value/EBITDA | 51 | ||
Enterprise Value/Revenue | 40 | ||
P/B | 11 | ||
P/E | 60 | ||
PEG | 0 | ||
Price/Free Cash Flow | 41 | ||
Price/Operating Cash Flow | 41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue